DK0496832T3 - Inhibering af PADGEM-formidlet cellebinding - Google Patents

Inhibering af PADGEM-formidlet cellebinding

Info

Publication number
DK0496832T3
DK0496832T3 DK90917479.9T DK90917479T DK0496832T3 DK 0496832 T3 DK0496832 T3 DK 0496832T3 DK 90917479 T DK90917479 T DK 90917479T DK 0496832 T3 DK0496832 T3 DK 0496832T3
Authority
DK
Denmark
Prior art keywords
padgem
inhibition
cell binding
mediated cell
cell
Prior art date
Application number
DK90917479.9T
Other languages
Danish (da)
English (en)
Inventor
Barbara C Furie
Bruce Furie
Eric Larsen
Alessandro Celi
Gary E Gilbert
John K Erban
Roberta Bonfanti
Denisa D Wagner
Original Assignee
New England Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Medical Center Inc filed Critical New England Medical Center Inc
Application granted granted Critical
Publication of DK0496832T3 publication Critical patent/DK0496832T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Networks Using Active Elements (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK90917479.9T 1989-10-20 1990-10-22 Inhibering af PADGEM-formidlet cellebinding DK0496832T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42488689A 1989-10-20 1989-10-20

Publications (1)

Publication Number Publication Date
DK0496832T3 true DK0496832T3 (da) 1996-12-30

Family

ID=23684279

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90917479.9T DK0496832T3 (da) 1989-10-20 1990-10-22 Inhibering af PADGEM-formidlet cellebinding

Country Status (9)

Country Link
EP (1) EP0496832B1 (de)
JP (1) JPH05504470A (de)
AT (1) ATE146218T1 (de)
CA (1) CA2067250C (de)
DE (1) DE69029398T2 (de)
DK (1) DK0496832T3 (de)
ES (1) ES2097765T3 (de)
GR (1) GR3022011T3 (de)
WO (1) WO1991006632A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021956A1 (en) * 1992-05-05 1993-11-11 Cytel Corporation Antibodies to p-selectin and their uses
US5800815A (en) * 1903-05-05 1998-09-01 Cytel Corporation Antibodies to P-selectin and their uses
US5464778A (en) * 1989-03-08 1995-11-07 Board Of Regents Of The University Of Oklahoma Glycoprotein ligand for P-selectin and methods of use thereof
US5753631A (en) * 1990-06-15 1998-05-19 Cytel Corporation Intercellular adhesion mediators
ATE224911T1 (de) * 1990-07-17 2002-10-15 Univ Oklahoma Gmp-140 ligand
US6309639B1 (en) 1991-02-05 2001-10-30 The Board Of Regents Of The University Of Oklahoma Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
US6124267A (en) * 1991-02-05 2000-09-26 Southpac Trust Internationals, Inc. O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
US5807745A (en) * 1991-03-11 1998-09-15 New England Medical Center Hospitals, Inc. Method of inhibiting PADGEM-mediated or ELAM-1-mediated leukocyte adhesion using an inhibitor comprising a Lex core component
CA2105997A1 (en) * 1991-03-11 1992-09-12 Bruce Furie Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component
CA2110495A1 (en) * 1991-06-10 1992-12-23 Robert M. Ippolito Immunosuppressive and tolerogenic oligosaccharide derivatives
US5646123A (en) * 1991-06-10 1997-07-08 Alberta Research Council Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen
JPH07507040A (ja) * 1991-09-10 1995-08-03 セントコー，インコーポレイテッド セレクチンによって介在される炎症のペプチド阻害剤
CA2120240A1 (en) * 1991-09-30 1993-03-31 Theresa M. Palabrica Inhibition of vascular narrowing using anti-padgen antibodies
JPH07501828A (ja) * 1991-12-18 1995-02-23 セントコー，インコーポレイテッド セレクチン類で仲介される炎症のペプチド阻害剤
US6033667A (en) * 1992-05-05 2000-03-07 Cytel Corporation Method for detecting the presence of P-selectin
EP0731709B1 (de) * 1992-05-11 2001-10-24 Corvas International, Inc. Neutrophilen inhibitoren aus nematoden
US5843707A (en) * 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
US6277975B1 (en) 1992-10-23 2001-08-21 Genetics Institute, Inc. Fusions of P-selectin ligand protein and polynucleotides encoding same
ATE256182T1 (de) * 1992-10-23 2003-12-15 Inst Genetics Llc Neuartiges p- selectin ligandenprotein
WO1994011498A1 (en) * 1992-11-16 1994-05-26 Board Of Regents Of The University Of Oklahoma Glycoprotein ligand for p-selectin and methods of use thereof
EP0804235A4 (de) * 1993-05-04 2001-09-19 Aeres Biomedical Ltd Antikörper gegen p-selectin und ihre verwendungen
AU2361395A (en) * 1994-04-28 1995-11-29 Genetics Institute Inc. Novel P-selectin ligand protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88308A0 (en) * 1987-11-17 1989-06-30 Scripps Clinic Res Peptides that block the binding of von willebrand factor
ATE224911T1 (de) * 1990-07-17 2002-10-15 Univ Oklahoma Gmp-140 ligand

Also Published As

Publication number Publication date
CA2067250A1 (en) 1991-04-21
ATE146218T1 (de) 1996-12-15
EP0496832A4 (en) 1993-02-17
EP0496832A1 (de) 1992-08-05
GR3022011T3 (en) 1997-03-31
DE69029398T2 (de) 1997-04-10
EP0496832B1 (de) 1996-12-11
CA2067250C (en) 2008-06-17
DE69029398D1 (de) 1997-01-23
WO1991006632A1 (en) 1991-05-16
ES2097765T3 (es) 1997-04-16
JPH05504470A (ja) 1993-07-15

Similar Documents

Publication Publication Date Title
DK0496832T3 (da) Inhibering af PADGEM-formidlet cellebinding
DE69014507D1 (de) Gerät zur Zellenvorbehandlung für Durchfluss-Zytometrie.
IT8019675A0 (it) Procedimento per rivelare ligandi in campioni di prova e relativo reagente analitico.
DE3671105D1 (de) Automatischer analysator mit freiem zugang zur probe.
DE68901632D1 (de) Reaktionsgefaess zur durchfuehrung von aufeinanderfolgenden analytischen testen.
DE3783042D1 (de) System zur automatisierung von testen.
DE68923389D1 (de) Detektorzelle für Flüssigkeitschromatographie.
DE3787771D1 (de) Elektrochemische Analysenmethode.
ES517080A0 (es) Procedimiento de inmunoanalisis para determinar una iodotironina en una muestra de analisis.
DE69434942D1 (de) Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben
DE69119750T2 (de) Messzelle für chemische oder biochemische proben
BR9401570A (pt) Aparelhagem para detecção de microorganismos em amostras de espécime de fluido
NO890867L (no) Fluidum-proevetaker, saerlig for benyttelse i en oljebroenn.
NO864113D0 (no) Fremgangsmaate for immonoassay, samt analysesett for dens utfoerelse.
NO910202L (no) Fremgangsmaate for aa identifisere hydrokarbonfoerende lag iundergrunnsformasjoner.
DE3853560D1 (de) Analytisches Element zur Vollblutuntersuchung.
DE69023426D1 (de) Behälter für Flüssigkeitsproben.
DE69021912D1 (de) Probeneinspritzzelle.
PT77153B (de) Drehzapfenlager fuer tueren insbesondere fuer pendeltueren
DK51485A (da) Immunanalyse til paavisning af analytter i biologiske proever
ES2166996T3 (es) Metodo y reactivo para controlar los niveles en sangre de compuestos antiplaquetarios.
DK492085A (da) Fluorescenspolarisationsbestemmelse, reagenser og fremgangsmaade til fremstilling af reagenser til bestemmelse af digitoxin
NL7900780A (nl) Werkwijze en analyse-inrichting ter bepaling van de hoeveelheid van in water aanwezige, opgeloste, vaste en met water niet mengbare, organische stoffen.
BR8605308A (pt) Sensor de profundidade de imersao para retiradas de amostras em aco liquido
ATE62752T1 (de) Vorrichtungen zur verwendung in chemischen analyseverfahren.